Comment on 'The dangers of non-randomized, observational studies. Experience from the COVID-19 epidemic'. Aspirin therapy in COVID-19: too soon to dismiss its benefits?

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad.

Kow CS; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
Ramachandram DS; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, UK.

J Antimicrob Chemother ; 78(4): 1134-1135, 2023 04 03.

Article in English | MEDLINE | ID: covidwho-2267143

Subject(s)

COVID-19; Epidemics; Humans; Aspirin/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Epidemics / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Antimicrob Chemother Year: 2023 Document Type: Article Affiliation country: Jac

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google